Post

Interesting technical approach. The scale-up data will be telling.

Good to see investment in next-generation process technology.

The ligand screening was AI-assisted — DFT calculations narrowed candidates fast.

The cryogenic grinding improved dissolution rate by 5-fold for this BCS Class II drug.

The hERG channel inhibition IC50 was >30 μM — no cardiac liability.